PMID- 8650221 OWN - NLM STAT- MEDLINE DCOM- 19960725 LR - 20191210 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 93 IP - 12 DP - 1996 Jun 11 TI - Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression. PG - 6073-8 AB - The high incidence of neurological disorders in patients afflicted with acquired immunodeficiency syndrome (AIDS) may result from human immunodeficiency virus type 1 (HIV-1) induction of chemotactic signals and cytokines within the brain by virus-encoded gene products. Transforming growth factor beta1 (TGF-beta1) is an immunomodulator and potent chemotactic molecule present at elevated levels in HIV-1-infected patients, and its expression may thus be induced by viral trans-activating proteins such as Tat. In this report, a replication-defective herpes simplex virus (HSV)-1 tat gene transfer vector, dSTat, was used to transiently express HIV-1 Tat in glial cells in culture and following intracerebral inoculation in mouse brain in order to directly determine whether Tat can increase TGF-beta1 mRNA expression. dSTat infection of Vero cells transiently transfected by a panel of HIV-1 long terminal repeat deletion mutants linked to the bacterial chloramphenicol acetyltransferase reporter gene demonstrated that vector-expressed Tat activated the long terminal repeat in a trans-activation response element-dependent fashion independent of the HSV-mediated induction of the HIV-1 enhancer, or NF-kappaB domain. Northern blot analysis of human astrocytic glial U87-MG cells transfected by dSTat vector DNA resulted in a substantial increase in steady-state levels of TGF-beta1 mRNA. Furthermore, intracerebral inoculation of dSTat followed by Northern blot analysis of whole mouse brain RNA revealed an increase in levels of TGF-beta1 mRNA similar to that observed in cultured glial cells transfected by dSTat DNA. These results provided direct in vivo evidence for the involvement of HIV-1 Tat in activation of TGF-beta1 gene expression in brain. Tat-mediated stimulation of TGF-beta1 expression suggests a novel pathway by which HIV-1 may alter the expression of cytokines in the central nervous system, potentially contributing to the development of AIDS-associated neurological disease. FAU - Rasty, S AU - Rasty S AD - Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, PA 15261, USA. FAU - Thatikunta, P AU - Thatikunta P FAU - Gordon, J AU - Gordon J FAU - Khalili, K AU - Khalili K FAU - Amini, S AU - Amini S FAU - Glorioso, J C AU - Glorioso JC LA - eng PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (RNA, Messenger) RN - 0 (Transforming Growth Factor beta) SB - IM MH - Animals MH - Brain/*metabolism/virology MH - Chlorocebus aethiops MH - Defective Viruses/genetics/physiology MH - *Gene Expression Regulation, Viral MH - Gene Transfer Techniques MH - *Genes, tat MH - HIV-1/genetics MH - Herpesvirus 1, Human/*genetics/physiology MH - Mice MH - RNA, Messenger/genetics/metabolism MH - Transforming Growth Factor beta/*genetics MH - Vero Cells MH - Virus Replication/physiology PMC - PMC39191 EDAT- 1996/06/11 00:00 MHDA- 1996/06/11 00:01 PMCR- 1996/12/11 CRDT- 1996/06/11 00:00 PHST- 1996/06/11 00:00 [pubmed] PHST- 1996/06/11 00:01 [medline] PHST- 1996/06/11 00:00 [entrez] PHST- 1996/12/11 00:00 [pmc-release] AID - 10.1073/pnas.93.12.6073 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6073-8. doi: 10.1073/pnas.93.12.6073.